USE OF BLOCKING AGENTS OF BONE MORPHOGENIE PROTEIN (BMP) SIGNALING FOR THE TREATMENT OF NEUROINFLAMMATORY AND NEURODEGENERATIVE DISEASES
摘要
The invention provides pharmaceutical compositions for the treatment of neuroinflammatory or neurodegenerative diseases comprising a single or a combination of several blocking agent(s) of Bone Morphogenic Protein (BMP) signaling. The invention further provides methods of treatment of neuroinflammatory or neurodegenerative diseases comprising administering to a patient in need thereof the pharmaceutical compositions of the invention.
申请公布号
EP2861620(A2)
申请公布日期
2015.04.22
申请号
EP20130736977
申请日期
2013.06.12
申请人
THE MEDICAL RESEARCH, INFRASTRUCTURE, AND HEALTH SERVICES FUND OF THE TEL AVIV MEDICAL CENTER
发明人
KARNI, ARNON;AMIR LEVI, YIFAT;URSHANSKI, NATALY;BERNADET FAINBERG, KARIN